Solving the billion dollar lumbar back pain problem with a novel, first to market, software solution.

Helping patients, making doctors’ lives easier, and decreasing the cost of care by reducing the incidence of false positive blood cultures.

StimGuard is developing products to treat overactive bladder.


Spinal Singularity is developing novel, first to market products in the urology space.


Neurvana has developed proprietary, first to market technology to treat cerebral vasospasm and cerebral aneurysms.